Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ENDOSTATIN Cause Hepatic function abnormal? 7 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Hepatic function abnormal have been filed in association with ENDOSTATIN. This represents 8.5% of all adverse event reports for ENDOSTATIN.

7
Reports of Hepatic function abnormal with ENDOSTATIN
8.5%
of all ENDOSTATIN reports
1
Deaths
1
Hospitalizations

How Dangerous Is Hepatic function abnormal From ENDOSTATIN?

Of the 7 reports, 1 (14.3%) resulted in death, 1 (14.3%) required hospitalization.

Is Hepatic function abnormal Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ENDOSTATIN. However, 7 reports have been filed with the FAERS database.

What Other Side Effects Does ENDOSTATIN Cause?

Myelosuppression (21) Nausea (10) Bone marrow failure (7) Gastrointestinal disorder (7) White blood cell count decreased (7) Disease progression (6) Hypertension (6) Leukopenia (6) Vomiting (6) Gastrointestinal toxicity (5)

What Other Drugs Cause Hepatic function abnormal?

NIVOLUMAB (1,131) PEMBROLIZUMAB (1,079) METHOTREXATE (1,054) CABOZANTINIB S-MALATE (912) CYCLOPHOSPHAMIDE (824) BEVACIZUMAB (769) PACLITAXEL (603) LENVATINIB (528) ATORVASTATIN (520) CYCLOSPORINE (508)

Related Pages

ENDOSTATIN Full Profile All Hepatic function abnormal Reports All Drugs Causing Hepatic function abnormal ENDOSTATIN Demographics